|4Jun 3, 4:13 PM ET

Duvall Diantha 4

4 · GENOCEA BIOSCIENCES, INC. · Filed Jun 3, 2022

Insider Transaction Report

Form 4
Period: 2022-06-02
Duvall Diantha
CHIEF FINANCIAL OFFICER
Transactions
  • Sale

    Common Stock

    2022-06-02$0.06/sh1,355$8175,388 total
Footnotes (1)
  • [F1]Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.

Documents

1 file
  • 4
    wf-form4_165428718048421.xmlPrimary

    FORM 4